Moderna, Inc. — Investor Relations & Filings
Moderna, Inc. is a biotechnology company pioneering the development of messenger RNA (mRNA) therapeutics and vaccines. The company's core platform utilizes mRNA to carry instructions that direct the body's cells to produce proteins, thereby preventing or treating diseases. This technology enables the rapid design, research, and production of new medicines. Moderna is widely recognized for developing one of the first COVID-19 vaccines. Its research and development pipeline extends to various therapeutic areas, including infectious diseases, immuno-oncology, rare diseases, and autoimmune disorders. The company's mission is to create a new generation of transformative medicines for patients by leveraging the potential of its mRNA platform.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| SCHEDULE 13G/A Filing | 2026-02-06 | English | |
| SCHEDULE 13G Filing | 2026-02-05 | English | |
| 8-K | 2026-01-12 | English | |
| PRIMARY DOCUMENT | 2026-01-06 | English | |
| 8-K | 2026-01-05 | English | |
| SC TO-I/A Filing | 2025-12-16 | English |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
5 filings
| |||||
| 31291869 | SCHEDULE 13G/A Filing | 2026-02-06 | English | ||
| 31292108 | SCHEDULE 13G Filing | 2026-02-05 | English | ||
| 12982899 | 8-K | 2026-01-12 | English | ||
| 12982900 | PRIMARY DOCUMENT | 2026-01-06 | English | ||
| 12982901 | 8-K | 2026-01-05 | English | ||
|
2025
10 filings
| |||||
| 31292099 | SC TO-I/A Filing | 2025-12-16 | English | ||
| 12982902 | 4 | 2025-12-15 | English | ||
| 12982903 | PRIMARY DOCUMENT | 2025-12-15 | English | ||
| 12982904 | Regulatory Filings 2025 | 2025-12-11 | English | ||
| 12982905 | PRIMARY DOCUMENT | 2025-12-11 | English | ||
| 12982906 | Regulatory Filings 2025 | 2025-12-09 | English | ||
| 12982908 | PRIMARY DOCUMENT | 2025-12-08 | English | ||
| 12982907 | PRIMARY DOCUMENT | 2025-12-08 | English | ||
| 12982909 | PRIMARY DOCUMENT | 2025-12-02 | English | ||
| 12982912 | PRIMARY DOCUMENT | 2025-12-02 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Moderna, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/30610/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=30610 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=30610 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=30610 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 30610}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Moderna, Inc. (id: 30610)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.